Search

You searched for "dementia"

97 results found

Improving cataract efficiency: insights and learnings from expert practitioners

1 December 2022 | | EYE - Cataract, EYE - Refractive, EYE - General
An evening surgical meeting sponsored by Théa Pharmaceuticals Ltd brought together leading experts to share insights and experience on practice strategies to enhance the efficiency of cataract surgery. Streamlining patient flow to optimise capacity and efficiency Qasim Mansoor, Consultant Ophthalmic...

Life in the glaucoma laboratory

2 October 2025 | | EYE - Glaucoma
When people ask me what life in the laboratory is really like, I often pause. On one hand, it is the romantic notion of pushing back the boundaries of science with the daily rhythm of experiments, data and easily obtained...

Black History Month

5 October 2026 | | EYE - General
Since it was first introduced in 1987 by Akyaaba Addai-Sebo, the UK Black History Month has served as a way to celebrate the achievements of people of Black origin in the UK [1]. According to a 2022 census done by...

PREVIEW: National Student Ophthalmology Conference (NSOC) 2024

4 March 2024 | NSOC, conferences, preview, event, congress, free, student, trainee, meeting
The annual National Student Ophthalmology Conference (NSOC) will return for its third year running On Sunday, March 24th, in a virtual setting.

Fundus photography in Malawi – setting up a screening programmefor diabetic retinopathy

1 August 2016 | | EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
We present the case of a 53-year-old lady who presented to the diabetes outpatient clinic at Kamuzu Central Hospital (KCH), Lilongwe, Malawi. She was diagnosed with type 2 diabetes mellitus six years ago, for which she takes metformin orally. She...

Brexit, for richer, for poorer: prospects for post-withdrawal Britain

1 July 2017 | | EYE - General
The people of the United Kingdom voted by 52% to 48% to leave the European Union (EU) in June 2016, a referendum decision intended by a slim majority to restore national self-determination and achieve what many believed to be a...

Labour peer immortalised in bronze to celebrate achievements of vision impaired people

22 October 2025 | fight for sight, David Blunkett, vision impairment, charity, politics
A bronze bust of Labour peer, the Rt Hon Lord David Blunkett – the UK’s first blind cabinet minister – has been unveiled at the House of Lords. The unveiling was part of a special event last night​​ by national...

In conversation with Charles Leclercq (ARxVision)

5 October 2022 | | EYE - General
Julian Jackson (Founder and Director, VisionBridge) spoke to Charles Leclercq (CEO, ARx) about the ARxVision, a wearable device that captures the world around us through audio and artificial intelligence to empower blind and low-vision individuals. You can read the Eye...

RCOphth Annual Congress 2022 - Preview

19 May 2022
Eye News previews the RCOphth Annual Congress 2022, as we look forward to the return of an in-person Congress for the first time since 2019. Follow updates and key events here.

Ocular bubbly: a vitreoretinal update on the art of gases

5 April 2022 | | EYE - Vitreo-Retinal, EYE - General
The authors remind us of the revolutionary impact gases have had on retinal surgery. In 1938, Rosengren attempted to improve his retina repair surgical outcomes [1]. He discovered that suturing the retina or pressing externally on the sclera were not...

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

29 March 2023 | glaucoma
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.

Ciliatech presents preliminary results on treating glaucoma with CID at Ophthalmology Futures Symposium

18 September 2023 | Glaucoma, CID, Ciliatech, Research
Ciliatech presents preliminary one-year study results on treating open- and narrow-angle glaucoma with CID at Ophthalmology Futures Symposium.